Metropolis Healthcare Ltd News

Stocks to watch today, May 14: Tata Motors, HAL, Eicher, Lupin, Airtel

At 6:40 AM, GIFT Nifty futures were trading 90 points higher at 24,730 level, indicating a higher start.

Metropolis Healthcare Q4 results: Net profit falls 19.9%, revenue up 4.3%

Metropolis Q4 profit dips due to one-off costs from acquisitions; FY25 profit rises 13.4% on demand for preventive testing and strong B2C, B2B growth

Metropolis Healthcare expands footprint in North with Dapic acquisition

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

Metropolis up 3% on plans to foray into Western UP with Scientific deal

Metropolis Healthcare plans to acquire Western UP-based Scientific Pathology on a slump sale basis

Metropolis strengthens UP presence with acquisition of Scientific Pathology

This is the second acquisition in the North India market this financial year; share of North market to grow from 8 per cent now to 18 per cent by end of FY26

Metropolis Healthcare shares gain 4% on posting Q3 results; PAT up 15 YoY

The company in the quarter ended December 31, 2024, reported a 15.3 per cent rise in consolidated net profit to Rs 31 crore as compared to Rs 27 crore a year ago

Metropolis Healthcare Q3 results: Net profit soars 15%, revenue up 10.8%

On a sequential basis, the company's revenue declined by 7.7 per cent, while PAT also fell by 32.5 per cent

Metropolis Healthcare, Roche team up to launch HPV DNA testing in India

"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said

Stocks to sell on rise: Apollo Tyres, Cyient may fall upto 34%, show charts

Metropolis Healthcare, Alembic Pharma and Tejas Networks are the other 3 stocks to witness a 'Death Cross' on the chart in recent days; technically this is a negative development for these stocks.

Chose growth over profitability: Core Diagnostics' Zoya on acquisition

India has several venture-backed startups for whom the natural consequence is to have an exit, and between profitability and growth in the journey ahead, "we opted for the latter", Zoya Brar, founder of Core Diagnostics, which was recently acquired by Metropolis Healthcare, said. Metropolis Healthcare, one of India's leading diagnostics chains, acquired specialised diagnostics company Core Diagnostics for Rs 246.8 crore last month. "For an organisation to scale, it can either do it organically or inorganically. Since we have a number of venture-backed startups (in India), the natural consequence is, there needs to be an exit. And while IPOs are an option, they need a certain volume and scale before it makes sense. So we will continue to see consolidation," Brar told PTI. "Most importantly, incumbents like Metropolis need to constantly differentiate themselves to remain ahead of the competitive landscape and one simple way to do that is to acquire insurgents that have built an ...

F&O Market: Union Bank, Dabur see short build-up as Nifty tumbles 300pts

Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.

Core acquisition adds to Metropolis Healthcare's long-term growth plans

Market share gains in the B2C portfolio are visible and Tier III+ markets are likely to contribute to the patient volume growth guidance